Neoadjuvant chemotherapy for locally advanced cervical cancer

Takashi Iwata, Azumi Miyauchi, Yukako Suga, Hiroshi Nishio, Masaru Nakamura, Akiko Ohno, Nobumaru Hirao, Toru Morisada, Kyoko Tanaka, Hiroki Ueyama, Hidemichi Watari, Daisuke Aoki

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Neoadjuvant chemotherapy followed by surgery (NCS) has not been fully evaluated clinically. Currently, the main regimen of neoadjuvant chemotherapy (NAC) used in NCS includes cisplatin. The antitumor effects of NAC reduce lymph node metastasis and the tumor diameter in patients prior to surgery, and this can reduce the number of high risk patients who require postoperative radiation therapy. Many randomized controlled trials (RCTs) have examined the long-term prognosis of NCS compared to primary surgery, but the utility of NCS remains uncertain. The advent of concurrent chemoradiotherapy (CCRT) has markedly improved the outcome of radiotherapy (RT), and CCRT is now used as a standard method in many cases of advanced bulky cervical cancer. NCS gives a better treatment outcome than radiation therapy alone, but it is important to verify that NCS gives a similar or better outcome compared to CCRT.

Original languageEnglish
Pages (from-to)235-240
Number of pages6
JournalChinese Journal of Cancer Research
Volume28
Issue number2
DOIs
Publication statusPublished - 2016 Apr 1

Fingerprint

Chemoradiotherapy
Uterine Cervical Neoplasms
Radiotherapy
Drug Therapy
Cisplatin
Randomized Controlled Trials
Lymph Nodes
Neoplasm Metastasis
Neoplasms

Keywords

  • Cervical cancer
  • Neoadjuvant chemotherapy (NAC)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Neoadjuvant chemotherapy for locally advanced cervical cancer. / Iwata, Takashi; Miyauchi, Azumi; Suga, Yukako; Nishio, Hiroshi; Nakamura, Masaru; Ohno, Akiko; Hirao, Nobumaru; Morisada, Toru; Tanaka, Kyoko; Ueyama, Hiroki; Watari, Hidemichi; Aoki, Daisuke.

In: Chinese Journal of Cancer Research, Vol. 28, No. 2, 01.04.2016, p. 235-240.

Research output: Contribution to journalReview article

Iwata, Takashi ; Miyauchi, Azumi ; Suga, Yukako ; Nishio, Hiroshi ; Nakamura, Masaru ; Ohno, Akiko ; Hirao, Nobumaru ; Morisada, Toru ; Tanaka, Kyoko ; Ueyama, Hiroki ; Watari, Hidemichi ; Aoki, Daisuke. / Neoadjuvant chemotherapy for locally advanced cervical cancer. In: Chinese Journal of Cancer Research. 2016 ; Vol. 28, No. 2. pp. 235-240.
@article{d5ea19802e5a40a49c26481232d0f276,
title = "Neoadjuvant chemotherapy for locally advanced cervical cancer",
abstract = "Neoadjuvant chemotherapy followed by surgery (NCS) has not been fully evaluated clinically. Currently, the main regimen of neoadjuvant chemotherapy (NAC) used in NCS includes cisplatin. The antitumor effects of NAC reduce lymph node metastasis and the tumor diameter in patients prior to surgery, and this can reduce the number of high risk patients who require postoperative radiation therapy. Many randomized controlled trials (RCTs) have examined the long-term prognosis of NCS compared to primary surgery, but the utility of NCS remains uncertain. The advent of concurrent chemoradiotherapy (CCRT) has markedly improved the outcome of radiotherapy (RT), and CCRT is now used as a standard method in many cases of advanced bulky cervical cancer. NCS gives a better treatment outcome than radiation therapy alone, but it is important to verify that NCS gives a similar or better outcome compared to CCRT.",
keywords = "Cervical cancer, Neoadjuvant chemotherapy (NAC)",
author = "Takashi Iwata and Azumi Miyauchi and Yukako Suga and Hiroshi Nishio and Masaru Nakamura and Akiko Ohno and Nobumaru Hirao and Toru Morisada and Kyoko Tanaka and Hiroki Ueyama and Hidemichi Watari and Daisuke Aoki",
year = "2016",
month = "4",
day = "1",
doi = "10.21147/j.issn.1000-9604.2016.02.13",
language = "English",
volume = "28",
pages = "235--240",
journal = "Chinese Journal of Cancer Research",
issn = "1000-9604",
publisher = "Beijing Institute for Cancer Research",
number = "2",

}

TY - JOUR

T1 - Neoadjuvant chemotherapy for locally advanced cervical cancer

AU - Iwata, Takashi

AU - Miyauchi, Azumi

AU - Suga, Yukako

AU - Nishio, Hiroshi

AU - Nakamura, Masaru

AU - Ohno, Akiko

AU - Hirao, Nobumaru

AU - Morisada, Toru

AU - Tanaka, Kyoko

AU - Ueyama, Hiroki

AU - Watari, Hidemichi

AU - Aoki, Daisuke

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Neoadjuvant chemotherapy followed by surgery (NCS) has not been fully evaluated clinically. Currently, the main regimen of neoadjuvant chemotherapy (NAC) used in NCS includes cisplatin. The antitumor effects of NAC reduce lymph node metastasis and the tumor diameter in patients prior to surgery, and this can reduce the number of high risk patients who require postoperative radiation therapy. Many randomized controlled trials (RCTs) have examined the long-term prognosis of NCS compared to primary surgery, but the utility of NCS remains uncertain. The advent of concurrent chemoradiotherapy (CCRT) has markedly improved the outcome of radiotherapy (RT), and CCRT is now used as a standard method in many cases of advanced bulky cervical cancer. NCS gives a better treatment outcome than radiation therapy alone, but it is important to verify that NCS gives a similar or better outcome compared to CCRT.

AB - Neoadjuvant chemotherapy followed by surgery (NCS) has not been fully evaluated clinically. Currently, the main regimen of neoadjuvant chemotherapy (NAC) used in NCS includes cisplatin. The antitumor effects of NAC reduce lymph node metastasis and the tumor diameter in patients prior to surgery, and this can reduce the number of high risk patients who require postoperative radiation therapy. Many randomized controlled trials (RCTs) have examined the long-term prognosis of NCS compared to primary surgery, but the utility of NCS remains uncertain. The advent of concurrent chemoradiotherapy (CCRT) has markedly improved the outcome of radiotherapy (RT), and CCRT is now used as a standard method in many cases of advanced bulky cervical cancer. NCS gives a better treatment outcome than radiation therapy alone, but it is important to verify that NCS gives a similar or better outcome compared to CCRT.

KW - Cervical cancer

KW - Neoadjuvant chemotherapy (NAC)

UR - http://www.scopus.com/inward/record.url?scp=85006055510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006055510&partnerID=8YFLogxK

U2 - 10.21147/j.issn.1000-9604.2016.02.13

DO - 10.21147/j.issn.1000-9604.2016.02.13

M3 - Review article

VL - 28

SP - 235

EP - 240

JO - Chinese Journal of Cancer Research

JF - Chinese Journal of Cancer Research

SN - 1000-9604

IS - 2

ER -